Click for best price
Lung Cancer Diagnostic Tests Market Size, Share 2022
This report contains market size and forecasts of Lung Cancer Diagnostic Tests in Global, including the following market information:
- Global Lung Cancer Diagnostic Tests Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Lung Cancer Diagnostic Tests market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Immunoassays Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lung Cancer Diagnostic Tests include Advpharma Inc, AIT Austrian Institute of Technology GmbH, Courtagen Life Sciences Inc, DiagnoCure Inc. (Inactive), BioMark Diagnostics Inc., BioMarker Strategies LLC, Emory University, Epigenomics AG and GlycoZym, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lung Cancer Diagnostic Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung Cancer Diagnostic Tests Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Diagnostic Tests Market Segment Percentages, by Type, 2021 (%)
- Immunoassays
- Flow Cytometry
- Rapid Tests
- Molecular Assays
- Tissue Arrays
- Circulating Tumor Cells
- Pharmacodiagnostics
- Biomarkers
- Other Diagnostics Methods
Global Lung Cancer Diagnostic Tests Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lung Cancer Diagnostic Tests Market Segment Percentages, by Application, 2021 (%)
- Precision Medicine
- Personalized Medicine
- Cancer Monitoring
Global Lung Cancer Diagnostic Tests Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lung Cancer Diagnostic Tests Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Lung Cancer Diagnostic Tests revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Lung Cancer Diagnostic Tests revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Advpharma Inc
- AIT Austrian Institute of Technology GmbH
- Courtagen Life Sciences Inc
- DiagnoCure Inc. (Inactive)
- BioMark Diagnostics Inc.
- BioMarker Strategies LLC
- Emory University
- Epigenomics AG
- GlycoZym
- HalioDx SAS
- Louisville Bioscience, Inc.
- Mayo Clinic US
| Report Attributes |
Report Details |
| Report Title |
Lung Cancer Diagnostic Tests Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Diagnostic Tests Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Diagnostic Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Diagnostic Tests Overall Market Size
2.1 Global Lung Cancer Diagnostic Tests Market Size: 2021 VS 2028
2.2 Global Lung Cancer Diagnostic Tests Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Diagnostic Tests Players in Global Market
3.2 Top Global Lung Cancer Diagnostic Tests Companies Ranked by Revenue
3.3 Global Lung Cancer Diagnostic Tests Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Diagnostic Tests Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lung Cancer Diagnostic Tests Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Diagnostic Tests Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Diagnostic Tests Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Diagnostic Tests Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Lung Cancer Diagnostic Tests Market Size Markets, 2021 & 2028
4.1.2 Immunoassays
4.1.3 Flow Cytometry
4.1.4 Rapid Tests
4.1.5 Molecular Assays
4.1.6 Tissue Arrays
4.1.7 Circulating Tumor Cells
4.1.8 Pharmacodiagnostics
4.1.9 Biomarkers
4.1.10 Other Diagnostics Methods
4.2 By Type - Global Lung Cancer Diagnostic Tests Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Diagnostic Tests Revenue, 2017-2022
4.2.2 By Type - Global Lung Cancer Diagnostic Tests Revenue, 2023-2028
4.2.3 By Type - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Diagnostic Tests Market Size, 2021 & 2028
5.1.2 Precision Medicine
5.1.3 Personalized Medicine
5.1.4 Cancer Monitoring
5.2 By Application - Global Lung Cancer Diagnostic Tests Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Diagnostic Tests Revenue, 2017-2022
5.2.2 By Application - Global Lung Cancer Diagnostic Tests Revenue, 2023-2028
5.2.3 By Application - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Lung Cancer Diagnostic Tests Market Size, 2021 & 2028
6.2 By Region - Global Lung Cancer Diagnostic Tests Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Diagnostic Tests Revenue, 2017-2022
6.2.2 By Region - Global Lung Cancer Diagnostic Tests Revenue, 2023-2028
6.2.3 By Region - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Lung Cancer Diagnostic Tests Revenue, 2017-2028
6.3.2 US Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.3.3 Canada Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.3.4 Mexico Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Diagnostic Tests Revenue, 2017-2028
6.4.2 Germany Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4.3 France Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4.4 U.K. Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4.5 Italy Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4.6 Russia Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4.7 Nordic Countries Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.4.8 Benelux Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Diagnostic Tests Revenue, 2017-2028
6.5.2 China Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.5.3 Japan Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.5.4 South Korea Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.5.5 Southeast Asia Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.5.6 India Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Lung Cancer Diagnostic Tests Revenue, 2017-2028
6.6.2 Brazil Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.6.3 Argentina Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Diagnostic Tests Revenue, 2017-2028
6.7.2 Turkey Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.7.3 Israel Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.7.4 Saudi Arabia Lung Cancer Diagnostic Tests Market Size, 2017-2028
6.7.5 UAE Lung Cancer Diagnostic Tests Market Size, 2017-2028
7 Players Profiles
7.1 Advpharma Inc
7.1.1 Advpharma Inc Corporate Summary
7.1.2 Advpharma Inc Business Overview
7.1.3 Advpharma Inc Lung Cancer Diagnostic Tests Major Product Offerings
7.1.4 Advpharma Inc Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.1.5 Advpharma Inc Key News
7.2 AIT Austrian Institute of Technology GmbH
7.2.1 AIT Austrian Institute of Technology GmbH Corporate Summary
7.2.2 AIT Austrian Institute of Technology GmbH Business Overview
7.2.3 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Major Product Offerings
7.2.4 AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.2.5 AIT Austrian Institute of Technology GmbH Key News
7.3 Courtagen Life Sciences Inc
7.3.1 Courtagen Life Sciences Inc Corporate Summary
7.3.2 Courtagen Life Sciences Inc Business Overview
7.3.3 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Major Product Offerings
7.3.4 Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.3.5 Courtagen Life Sciences Inc Key News
7.4 DiagnoCure Inc. (Inactive)
7.4.1 DiagnoCure Inc. (Inactive) Corporate Summary
7.4.2 DiagnoCure Inc. (Inactive) Business Overview
7.4.3 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Major Product Offerings
7.4.4 DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.4.5 DiagnoCure Inc. (Inactive) Key News
7.5 BioMark Diagnostics Inc.
7.5.1 BioMark Diagnostics Inc. Corporate Summary
7.5.2 BioMark Diagnostics Inc. Business Overview
7.5.3 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Major Product Offerings
7.5.4 BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.5.5 BioMark Diagnostics Inc. Key News
7.6 BioMarker Strategies LLC
7.6.1 BioMarker Strategies LLC Corporate Summary
7.6.2 BioMarker Strategies LLC Business Overview
7.6.3 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Major Product Offerings
7.6.4 BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.6.5 BioMarker Strategies LLC Key News
7.7 Emory University
7.7.1 Emory University Corporate Summary
7.7.2 Emory University Business Overview
7.7.3 Emory University Lung Cancer Diagnostic Tests Major Product Offerings
7.7.4 Emory University Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.7.5 Emory University Key News
7.8 Epigenomics AG
7.8.1 Epigenomics AG Corporate Summary
7.8.2 Epigenomics AG Business Overview
7.8.3 Epigenomics AG Lung Cancer Diagnostic Tests Major Product Offerings
7.8.4 Epigenomics AG Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.8.5 Epigenomics AG Key News
7.9 GlycoZym
7.9.1 GlycoZym Corporate Summary
7.9.2 GlycoZym Business Overview
7.9.3 GlycoZym Lung Cancer Diagnostic Tests Major Product Offerings
7.9.4 GlycoZym Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.9.5 GlycoZym Key News
7.10 HalioDx SAS
7.10.1 HalioDx SAS Corporate Summary
7.10.2 HalioDx SAS Business Overview
7.10.3 HalioDx SAS Lung Cancer Diagnostic Tests Major Product Offerings
7.10.4 HalioDx SAS Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.10.5 HalioDx SAS Key News
7.11 Louisville Bioscience, Inc.
7.11.1 Louisville Bioscience, Inc. Corporate Summary
7.11.2 Louisville Bioscience, Inc. Business Overview
7.11.3 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Major Product Offerings
7.11.4 Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.11.5 Louisville Bioscience, Inc. Key News
7.12 Mayo Clinic US
7.12.1 Mayo Clinic US Corporate Summary
7.12.2 Mayo Clinic US Business Overview
7.12.3 Mayo Clinic US Lung Cancer Diagnostic Tests Major Product Offerings
7.12.4 Mayo Clinic US Lung Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.12.5 Mayo Clinic US Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Lung Cancer Diagnostic Tests Market Opportunities & Trends in Global Market
Table 2. Lung Cancer Diagnostic Tests Market Drivers in Global Market
Table 3. Lung Cancer Diagnostic Tests Market Restraints in Global Market
Table 4. Key Players of Lung Cancer Diagnostic Tests in Global Market
Table 5. Top Lung Cancer Diagnostic Tests Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lung Cancer Diagnostic Tests Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lung Cancer Diagnostic Tests Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lung Cancer Diagnostic Tests Product Type
Table 9. List of Global Tier 1 Lung Cancer Diagnostic Tests Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Diagnostic Tests Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lung Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lung Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lung Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lung Cancer Diagnostic Tests Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lung Cancer Diagnostic Tests Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lung Cancer Diagnostic Tests Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2023-2028
Table 30. Advpharma Inc Corporate Summary
Table 31. Advpharma Inc Lung Cancer Diagnostic Tests Product Offerings
Table 32. Advpharma Inc Lung Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 33. AIT Austrian Institute of Technology GmbH Corporate Summary
Table 34. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Product Offerings
Table 35. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 36. Courtagen Life Sciences Inc Corporate Summary
Table 37. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Product Offerings
Table 38. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 39. DiagnoCure Inc. (Inactive) Corporate Summary
Table 40. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Product Offerings
Table 41. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 42. BioMark Diagnostics Inc. Corporate Summary
Table 43. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Product Offerings
Table 44. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 45. BioMarker Strategies LLC Corporate Summary
Table 46. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Product Offerings
Table 47. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 48. Emory University Corporate Summary
Table 49. Emory University Lung Cancer Diagnostic Tests Product Offerings
Table 50. Emory University Lung Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 51. Epigenomics AG Corporate Summary
Table 52. Epigenomics AG Lung Cancer Diagnostic Tests Product Offerings
Table 53. Epigenomics AG Lung Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 54. GlycoZym Corporate Summary
Table 55. GlycoZym Lung Cancer Diagnostic Tests Product Offerings
Table 56. GlycoZym Lung Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 57. HalioDx SAS Corporate Summary
Table 58. HalioDx SAS Lung Cancer Diagnostic Tests Product Offerings
Table 59. HalioDx SAS Lung Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 60. Louisville Bioscience, Inc. Corporate Summary
Table 61. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Product Offerings
Table 62. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
Table 63. Mayo Clinic US Corporate Summary
Table 64. Mayo Clinic US Lung Cancer Diagnostic Tests Product Offerings
Table 65. Mayo Clinic US Lung Cancer Diagnostic Tests Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Lung Cancer Diagnostic Tests Segment by Type in 2021
Figure 2. Lung Cancer Diagnostic Tests Segment by Application in 2021
Figure 3. Global Lung Cancer Diagnostic Tests Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Diagnostic Tests Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lung Cancer Diagnostic Tests Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lung Cancer Diagnostic Tests Revenue in 2021
Figure 8. By Type - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 12. US Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 16. Germany Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 17. France Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 24. China Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 28. India Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 30. Brazil Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lung Cancer Diagnostic Tests Revenue Market Share, 2017-2028
Figure 33. Turkey Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lung Cancer Diagnostic Tests Revenue, (US$, Mn), 2017-2028
Figure 37. Advpharma Inc Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AIT Austrian Institute of Technology GmbH Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Courtagen Life Sciences Inc Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. DiagnoCure Inc. (Inactive) Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BioMark Diagnostics Inc. Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BioMarker Strategies LLC Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Emory University Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Epigenomics AG Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlycoZym Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. HalioDx SAS Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Louisville Bioscience, Inc. Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Mayo Clinic US Lung Cancer Diagnostic Tests Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
